Project Grant R01AI195699
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $402,150 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 23, 2025, with a completion date of June 30, 2027. This research project investigates the viral mechanisms by which Kaposi's Sarcoma-Associated Herpesvirus (KSHV) engages lytic cycle-promoting host...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida Division of Sponsored Research a Project Grant of $1,016,887 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 6, 2025, with a completion date of July 31, 2030. This award supports research to discover and develop novel HIV-1 Tat protein-degrading molecules as therapeutic agents to disrupt HIV transcription and promote viral latency. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $502,248 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective June 6, 2025, with completion targeted for May 31, 2030. This research initiative focuses on investigating the STING (Stimulator of Interferon Genes) pathway's role in protecting human intestinal epithelial cells from rotavirus infection. The project will...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $188,059 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 22, 2025, with completion targeted for December 31, 2027. This research project will deliver a comprehensive characterization of multi-drug resistant (MDR) bacterial transmission patterns and evolution...
- Federal Grant Award Summary The University of Florida Division of Sponsored Research received a $424,223 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 10, 2025, with completion anticipated by May 31, 2027. This award supports biomedical research investigating lipid-gene molecular profiles in sepsis-induced acute respiratory distress syndrome (ARDS). The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida $125,596.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 9, 2025, for a Mid-Career Investigator Award (K24) supporting Dr. Ali Zarrinpar's five-year research and mentoring initiative through August 31, 2030. The award funds patient-oriented research (POR) in transplant immunobiology and immunometabolism, specifically...
- Federal Project Grant Award Summary The University of Florida, Division of Sponsored Research, received a $422,125 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 23, 2025, with completion targeted for June 30, 2027. This grant funds research to develop a novel vaccine against Francisella tularensis, a highly pathogenic bacterium with a mortality rate exceeding 60% that...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of South Florida $412,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning July 3, 2025, with completion targeted for June 30, 2027. This Project Grant supports research focused on evaluating immunodominant fragments of Plasmodium falciparum glutamic acid-rich protein A (PfGARP) for malaria vaccine development. The research addresses a critical...
- Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $137,064 to the University of Florida under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 25, 2025, for a two-year project concluding June 30, 2027. This Project Grant supports the development and validation of novel conceptual frameworks to model healthcare accessibility using system science approaches. The research will pioneer two distinct modeling methodologies—system...
- Federal Grant Award Summary Florida State University received a $1,389,743 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 1, 2025, through February 28, 2030. The award supports research on membrane protein complexes in the Mycobacterium tuberculosis divisome to advance understanding of bacterial cell division mechanisms critical for developing new tuberculosis...
The University of Florida's Division of Sponsored Research received a $667,735 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of February 13, 2026 and a completion date of January 31, 2031. This grant funds research investigating potassium channel regulation of antiviral immune responses, with the objective of identifying novel regulators of immunity and potential therapeutic targets for viral diseases. The research will examine how ATP-gated inward rectifier potassium (KATP) channels regulate antiviral immune responses across multiple physiological systems, including circulatory homeostasis, RNA interference (RNAi) machinery function, and reactive oxygen species generation in model organisms to inform understanding of human antiviral immunity. The research project will deliver systematic experimental findings through three specific aims that test KATP channel involvement in viral immunity. These deliverables include scientific data on the influence of viral infection and K+ efflux modulation on dorsal vessel contraction dynamics and circulatory homeostasis, mechanistic insights into how KATP channels regulate antiviral RNAi machinery, and characterization of how aerobic respiration products regulate antiviral immune pathways. The results will advance fundamental knowledge of ion channel biology and immune regulation, potentially identifying KATP channels as therapeutic intervention points for improving antiviral immune responses in humans.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $667.7k | 2/13/26 |